| Nome del prodotto |
disolfato di butirosina |
| Sinonimi |
Butirosina solfato anidro [USAN]; Solfato di butirosina; Solfato di ambutirrosina; Butirosina solfato anidro; Solfato di butirosina; Butirosina solfato anidro; Butirosina, solfato (sale); CL 642; D-streptammina, O-2,6-diammino-2,6-dideossi-alfa-D-glucopiranosil-(1-4)-O-(beta-D-xilofuranosil-(1-5))-N(sup 1)-(4-ammino-2-idrossi-1-ossobutil)-2-deossi-, (S)-, solfato (1:2) (sale) miscela diidrato con O-2,6-diammino-2,6-dideossi-alfa-D-glucopiranosil-(1-4)-O-(beta-D-ribofuranosil-(1-5))-N(sup 1)-((S)-4-ammino-2-idrossi-1-ossobutil)-2-deossi-D-streptamina solfato (1:2) (sale) anidro; O-2,6-diammino-2,6-dideossi-alfa-D-glucopiranosil-(1-4)-O-(beta-D-xilofuranosil-(1-5))-N(sup 1)-(4-ammino-L-2-idrossibutirril)-2-deossi-D-streptamina solfato (1:2) (sale) miscela diidrato con O-2,6-diammino-2,6-dideossi-alfa-D-glucopiranosil-(1-4)-O-(beta-D-ribofuranosil-(1-5))-N(sup 1)-(4-ammino-L-2-idrossibutirril)-2-deossi-D-streptamina solfato (1:2) (sale) anidro; 4-ammino-N-{(1R,2S,3R,4R,5S)-5-ammino-4-[(2,6-diammino-2,6-dideossi-alfa-D-glucopiranosil)ossi]-2-idrossi-3-[(3xi)-beta-D-eritro-pentofuranosilossi]cicloesil}-2-idrossibutanamide solfato idrato (1:2:2); 4-ammino-N-[(2R,3R)-5-ammino-4-[(2,6-diammino-2,6-dideossi-L-eritro-esopiranosil)ossi]-2-idrossi-3-(D-lissofuranosilossi)cicloesil]-2-idrossibutanamide disolfato (sale) |
| Nome inglese |
butirosin disulfate;Butirosin sulfate anhydrous [USAN]; Butirosin sulfate; Ambutyrosin sulfate; Butirosin sulfate anhydrous; Butirosin sulphate; Butirosin sulphate anhydrous; Butirosin, sulfate (salt); CL 642; D-Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-xylofuranosyl-(1-5))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-, sulfate (1:2) (salt) dihydrate mixture with O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-ribofuranosyl-(1-5))-N(sup 1)-((S)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-D-streptamine sulfate (1:2) (salt) anhydrous; O-2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-xylofuranosyl-(1-5))-N(sup 1)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-D-streptamine sulfate (1:2) (salt) dihydrate mixture with O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-ribofuranosyl-(1-5))-N(sup 1)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-D-streptamine sulfate (1:2) (salt) anhydrous; 4-amino-N-{(1R,2S,3R,4R,5S)-5-amino-4-[(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxy-3-[(3xi)-beta-D-erythro-pentofuranosyloxy]cyclohexyl}-2-hydroxybutanamide sulfate hydrate (1:2:2); 4-amino-N-[(2R,3R)-5-amino-4-[(2,6-diamino-2,6-dideoxy-L-erythro-hexopyranosyl)oxy]-2-hydroxy-3-(D-lyxofuranosyloxy)cyclohexyl]-2-hydroxybutanamide disulfate (salt) |
| Formula molecolare |
C21H45N5O20S2 |
| Peso Molecolare |
751.7335 |
| InChI |
InChI=1/C21H41N5O12.2H2O4S/c22-2-1-8(28)19(34)26-7-3-6(24)17(37-20-11(25)15(32)13(30)9(4-23)35-20)18(12(7)29)38-21-16(33)14(31)10(5-27)36-21;2*1-5(2,3)4/h6-18,20-21,27-33H,1-5,22-25H2,(H,26,34);2*(H2,1,2,3,4)/t6?,7?,8?,9?,10-,11+,12-,13?,14+,15-,16+,17?,18-,20?,21?;;/m1../s1 |
| Numero CAS |
51022-98-1 |
| Struttura molecolare |
|
| Punto di ebollizione |
947.4°C at 760 mmHg |
| Punto d'infiammabilità |
526.8°C |
| Pressione di vapore |
0mmHg at 25°C |
| Simboli di pericolo |
|
| Codici di Rischio |
|
| Sicurezza Descrizione |
|
|
